NCT00219791View on ClinicalTrials.gov

Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2000

Study Completion Date

June 30, 2003

Conditions
Neoplasms
Interventions
DRUG

glucarpidase (50 Units/kg)

Trial Locations (1)

12200

Charite - Universitätsmedizin Berlin, Berlin

Sponsors
All Listed Sponsors
lead

BTG International Inc.

OTHER